DEBORAH TRUESDELL: Open Payments
NPI 1063885408 · INDEPENDENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,599 in 71 payments from 20 companies in 2025. Trend: 2023 $1,663 · 2024 $1,895 · 2025 $2,599
Food & beverage: $2,599
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $889 |
| AstraZeneca Pharmaceuticals LP | 5 | $403 |
| Novo Nordisk Inc | 8 | $260 |
| Lilly USA, LLC | 4 | $160 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| Amgen Inc. | 6 | $99 |
| PFIZER INC. | 5 | $85 |
| Astellas Pharma US Inc | 3 | $80 |
| Abbott Laboratories | 3 | $61 |
Products named: VRAYLAR, UBRELVY, AIRSUPRA, Wegovy, QULIPTA, BREZTRI, Auvelity, Kerendia.
Industry payments across KY — which companies pay providers there.
